300+ Companies
Established hub
Deals 2019 Q4
8 investments
No acquisitions
Index Pro Account
Upgrade your account to download a CSV export of companies on any list
Pulse 2.0

How Kyverna Is Engineering A Class Of Therapies For Serious Autoimmune Diseases


Third Time’s the Charm as Acceleron Drug Shows Early Promise in PAH

the home of AI info

Neuroscience Market Witnessing New Frontiers from Growing Translational Research on ...

3D Printing Industry

Researchers develop Hybrid Living Materials using inkjet 3D printing


How Music Can Help Veterans


Goop on psychedelics isn’t bad, it’s just boring


Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK'd & More

Forbes Tech

Former Billionaire John Kapoor, Founder Of Insys Therapeutics, Sentenced To 5.5 Years In Prison

Seeking Alpha

BioXcel Therapeutics: AI-Focused Biopharmaceutical Player For 2020


FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs

the home of AI info

Huge Demand of Traumatic Brain Injuries Treatment Market by 2026 with Top Key Players like ...

MedCity News

Digital therapeutics can solve the greatest unmet need in behavioral healthcare: early intervention

MedCity News

Digital health, digital therapeutics, digital medicines - what's in a name?


Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More


Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal


Frazier Healthcare Partners raises $617M life sciences fund


Phage Therapy Firm APT Lands DoD Contract for Antibiotic Alternative

the home of AI info

ZebiAI Therapeutics, Inc. Announces Collaboration With Google Accelerated Science to Focus on ...

the home of AI info

AI startup Zebiai inks new deals with Google and X-Chem


A biotech startup thinks its idea could cure dementia—but scientists have their doubts